SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : ahhaha's ahs
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Lhn512/6/2013 1:19:42 PM
of 24758
 
Men everywhere rejoice:

Dec 6 (Reuters) - U.S. health regulators on Friday approvedAuxilium Pharmaceuticals Inc's Xiaflex injections totreat a condition that causes a painful curvature of the peniscalled Peyronie's disease.

It marks the second U.S. approval for Xiaflex, which in 2010received a Food and Drug Administration nod to treat Dupuytren'scontracture - a condition in which hardening of the connectivetissue collagen in the hands bends fingers toward the palm,leaving a patient unable to straighten their hands or use theirfingers properly.

Xiaflex is now the first FDA-approved non-surgical treatmentoption for men with Peyronie's disease who have a plaque buildupin the penis that results in a curvature deformity of at least30 degrees upon erection, the agend.

The drug is injected directly into the collagen buildup tobreak it down in order to help restore normal function to thepenis or hands.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News